Literature DB >> 10212345

White-coat hypertension: not guilty when correctly defined.

.   

Abstract

The coexistence of persistently high office blood pressure with normal blood pressujre outside the medical setting is often referred to as 'white-coat', 'office' or 'isolated clinic' hypertension. The definition of normal blood pressure outside the medical setting is controversial. In our experience, not only the prevalence of white-coat hypertension, but also left ventricular mass measured echocardiographically and the prevalence of left ventricular hypertrophy in this condition markedly vary on going from more restrictive (lower) to more liberal (higher) limits of ambulatory blood pressure normalcy over quite a narrow range. In a prospective study, cardiovascular morbidities of healthy normotensive controls and subjects with white-coat hypertension did not differ. A more recent analysis of our database supports the use of qujite a restrictive definition of white-coat hypertension (average daytime blood pressure < 130/80 mmHg) in order to identify the minority of subjects who have a low risk of cardiovascular morbid events during the subsequent years. A recent document published by the American Society of Hypertension suggests that slightly higher upper limits of ambulatory blood pressure normalcy (i.e. average daytime blood pressure < 135 mmHg systolic and 85 mmHg diastolic) should be used. In a follow-up study by our group, 37% of subjects with white-coat hypertension spontaneously evolved into cases of ambulatory hypertension, with accompanying increases in left ventricular mass. In that study, the probability of a subject developing ambulatory hypertension increased with the baseline values of ambulatory blood pressure and it was quite low (20%) for those with daytime blood pressures below 130/80 mmHg. In two recent controlled studies, the rate of development of ambulatory hypertension over time for untreated subjects did not differ between the normotensive control group and the group with white-coat hypertension. A final answer regarding the clinical significance of white-coat hypertension will come from very large surveys of the natural history of this condition in the long term. For now, we suggest a verdict of innocence for white-coat hypertension when low values of daytime ambulatory blood pressure (i.e. < 130/80 mmHg) and absence of organ lesions and other risk factors coexist.

Entities:  

Year:  1998        PMID: 10212345

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  10 in total

Review 1.  Circadian rhythm of blood pressure in renal disease.

Authors:  M Schömig; V Schwenger; E Ritz
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

2.  Twenty-four hour ambulatory blood pressure monitoring in adolescents with type 1 diabetes: getting started.

Authors:  Margaret Pellizzari; Phyllis W Speiser; Dennis E Carey; Pavel Fort; Paula M Kreitzer; Graeme R Frank
Journal:  J Diabetes Sci Technol       Date:  2008-11

3.  Predictive Factors of Abnormal Circadian Blood Pressure Profile in Recipients of Kidney Transplantation.

Authors:  Camelia Achim; Anca Zgura; Mihai Voiculescu
Journal:  Maedica (Buchar)       Date:  2016-06

4.  Microalbuminuria in children with primary and white-coat hypertension.

Authors:  Tomáš Seeman; Michael Pohl; Daniela Palyzova; Ulrike John
Journal:  Pediatr Nephrol       Date:  2011-10-05       Impact factor: 3.714

5.  Effects of stress and behavioral interventions in hypertension: what is masked hypertension?

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Mar-Apr       Impact factor: 3.738

Review 6.  Ambulatory blood pressure monitoring as an investigative tool for characterizing resistant hypertension and its rational treatment.

Authors:  William B White
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-01       Impact factor: 3.738

Review 7.  Diagnostic thresholds for ambulatory blood pressure moving lower: a review based on a meta-analysis-clinical implications.

Authors:  Tine W Hansen; Masahiro Kikuya; Lutgarde Thijs; Yan Li; José Boggia; Kristina Björklund-Bodegârd; Christian Torp-Pedersen; Jørgen Jeppesen; Hans Ibsen; Jan A Staessen
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-05       Impact factor: 3.738

8.  Out-of-office blood pressure: from measurement to control.

Authors:  Jean-Philippe Baguet
Journal:  Integr Blood Press Control       Date:  2012-05-16

9.  Prevalence, predictive factor, and clinical significance of white-coat hypertension and masked hypertension in Korean hypertensive patients.

Authors:  Eui-Seock Hwang; Kee-Joon Choi; Duk-Hyun Kang; Gi-Byoung Nam; Jae-Sik Jang; Young-Hoon Jeong; Chang-Hoon Lee; Ji-Young Lee; Hyun-Koo Park; Chong-Hun Park
Journal:  Korean J Intern Med       Date:  2007-12       Impact factor: 2.884

10.  Treatment of hypertension in the elderly.

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-10       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.